A Basel biotech bets $135M that a vaccine can stop cancer early
Nouscom closed an oversubscribed $135M Series D to run a registration-enabling trial…
Can anyone actually trust an AI scientist in the lab
LatchBio CTO Kenny Workman explains how his team turns real biology workflows…
Oxford spin-out OMass collects €275M for stubborn drug targets
OMass Therapeutics closed an oversubscribed €275M Series C to push small-molecule medicines…
Health tech founders pitch for the Startup Battlefield cup
Six-minute pitches and six minutes of grilling decide which health startups advance…
Danish biotech Breye raises €67.5M for oral eye therapy
The Copenhagen biotech will use the oversubscribed round to push oral drugs…
Anthropic puts Claude to work at a Bay Area wet lab
The model maker has confirmed it runs a physical biology laboratory, pairing…
Pixelgen banks €13.26M from Flat Capital for cell mapping
Stockholm's Pixelgen lands €13.26M led by Flat Capital to expand nanoscale mapping…
